Stock market today: At 7:48 AM, the GIFT NIFTY futures were trading 18.50 points, or 0.07% higher at 26,048.50 levels. This, as per publicly available information, indicates that NIFTY50 will open around 50 points higher.
Here is a list of stocks that may remain in focus today.
IDFC: IDFC Ltd on Wednesday, September 25, that it has received a green light from the National Company Law Tribunal (NCLT), Chennai, for the merger of IDFC Financial Holding Company with IDFC and their merger into IDFC First Bank.
Vedanta: Mining major
Vedanta said on Wednesday, September 25, that its board will meet on October 8 to consider a fourth interim dividend for FY25. The record date for the dividend, if declared, will be October 16.
Pharma stocks: Shares of pharma companies are expected to be in focus as in its latest monthly drug alert list, the Central Drugs Standards Control Organisation (CDSCO) declared 53 drugs as "Not of Standard Quality (NSQ) Alert."
Infosys: The IT major has collaborated with Swedish electric performance car brand Polestar to create a base for the latter's development of in-car infotainment, software and electrical/electronics engineering, user experience, and cloud-powered digital services.
As part of this partnership, Infosys will establish a global technology hub for Polestar at its development centre in Bengaluru, a regulatory filing said.
PB Fintech: The parent firm of Policybazaar is exploring plans to venture into the healthcare sector by establishing its own chain of hospitals, as per a report by CNBC TV-18. However, the company has not provided any official comment regarding this development.
Zen Technologies:
Zen Technologies, one of the leading providers of anti-drone technology and defense training solutions, in collaboration with its subsidiary AI Turing Technologies, on Wednesday, September 25, unveiled four revolutionary remote-controlled weapon and surveillance systems. These state-of-the-art innovations are poised to redefine modern warfare and strengthen India's defense prowess.
ONGC: The oil upstream company, in its exchange filing on Wednesday, September 25, said that its board of directors has approved the government's decision to infuse an additional ₹10,501 crore in ONGC Petro Additions.
SpiceJet: As per reports, Societe Generale has sold shares worth ₹47 crore in SpiceJet through block deals on Wednesday.
Five Star Finance: Five-Star Business Finance Ltd. holders will divest stake worth ₹4,317 crore through a secondary block deal on Thursday. As per a report by NDTV Profit, the issue has a lockup period of 12 months post-cross for selling shareholders.
The floor price for the deal has been set at ₹768 per share. This is at a discount of 5% to the closing price of ₹808 apiece. The holders are looking to offload 5.62 crore shares, representing 19.22% of the company.
ASK Automotive: The company on Wednesday (September 25) said Kuldip Singh Rathee, one of the promoters of the company, has announced plans to sell a 6.05% equity stake through an offer for sale (OFS). The OFS is scheduled for September 27-28, 2024.
"The floor price for the sale is set at ₹433 per share, with the base issue consisting of 5.50% equity, equivalent to 1.08 crore shares, along with a greenshoe option of 0.55%, or 10.8 lakh shares. JM Financial Services and ICICI Securities are the brokers for the sale," said a report by CNBC TV-18.
KPR Mill: SBI Mutual Fund on Wednesday hiked its stake in KPR Mill to 7.74% by snapping up additional 2.85% shares worth over ₹900 crore through an open market transaction.
According to the bulk deal data on the BSE, SBI Mutual Fund bought 9.735 million shares, or 2.85% stake, in apparel manufacturing company KPR Mill.
Adani Green Energy: Promoter entities Hibiscus Trade and Ardour Investment Holding bought 2.96% equity in the company between July 30-September 23, 2024.
Puravankara: As per a report by The Economic Times, the real estate developer has acquired 2.3 acres of land in Bengaluru from Citrus Venture Projects for around ₹135 crore.
Cipla: The pharma company said that Cipla (EU), a wholly-owned subsidiary of the company in the UK has entered into a definitive agreement on September 25, 2024, for the purchase of the entire 6.9124% equity interest of Jiangsu Xidi Pharmaceuticals (formerly known as Jiangsu Acebright Pharmaceuticals Co., Ltd.) held in Cipla (Jiangsu) Pharmaceuticals Co., Ltd., China (‘Cipla Jiangsu’), subsidiary.